Shelley, et al., Yesterday I filled out this form at the NIH "Portal" where any and everyone is encouraged to let NIAID know about anything they think will help fight Covid-19.

https://grants.nih.gov/grants/rfi/rfi.cfm?ID=107

I think having a bunch of people fill out this form and advocate for Cytodyn and Leronlimab wouldn't be a bad idea. Let's call their bluff. I filled out the form as an "Advocate". Here is what I said in the comment section -

I see that NIH is enrolling candidates for therapeutics to fight Covid-19. Is NIH unaware that a highly effective therapeutic for Covid-19 already exists and is in trials with the FDA?

The therapeutic in a humanized monoclonal antibody made by Cytodyn Inc. in Vancouver, Washington and is called Leronlimab. Cytodyn has filed for a BLA for Leronlimab to treat HIV and is in Phase 3 trials for treating Covid-19 for severe to critical patients and has just finished Phase 2 trials for mild to moderate cases of Covid-19 and has applied for Emergency Use Authorization.

The safety profile of Leronlimab has proven to be excellent in all uses. Some trial participants in the HIV trials have been using it for 6 years. There have been no serious safety concerns ever.

Leronlimab should be granted EUA status and should be made the Standard of Care for Covid-19 immediately, replacing the current SOC, Remdesivir.

I have searched NIH's website and I find no evidence that you are aware of Cytodyn and Leronlimab. Is this true? If so, please research Cytodyn and Leronlimab and add them to your database. Also please call Cytodyn at 360-980-8524.

Thank you.

You could also add now that Plasma is crap by comparison!